We would also like to acknowledge the Carlsberg Foundation
(to S. S. and K. R. K.) and the Novartis Research Fellowship (to
S. V. L.) for their financial support. We also thank Dr. G. Zinzalla
and L. Milroy for the preparation of imine 8.
Table 2 Study of flow hydrogenation scope
Entry Imine
Yield (%)a Purity (%)
1
quant.
.95
Steen Saaby,a Kristian Rahbek Knudsen,a Mark Ladlowb and
Steven V. Ley*a
aDepartment of Chemistry, University of Cambridge, Lensfield Road,
Cambridge, UK CB2 1EW. E-mail: svl1000@cam.ac.uk;
Fax: 44 (0) 1223 336442; Tel: 44 (0) 1223 336398
bGlaxoSmithKline Cambridge Technology Centre, University of
Cambridge, Cambridge, UK CB2 1EW
2
3
4
93
.95
Notes and references
1 S. V. Ley and I. R. Baxendale, Nat. Rev. Drug Discovery, 2002, 1,
573.
quant.
quant.
95
2 (a) W. Ehrfeld, V. Hessel and H. Lo¨we, Microreactors: New Technology
for Modern Chemistry, Wiley-VCH, Weinheim, 2000; (b) A. M. Hafez,
A. E. Taggi, H. Wack, W. J. Drury, III and T. Lectka, Org. Lett., 2000,
2, 3963; (c) A. M. Hafez, A. E. Taggi, T. Dudding and T. Lectka, J. Am.
Chem. Soc., 2001, 123, 10853; (d) N. G. Anderson, Org. Process Res.
Dev., 2001, 5, 613; (e) M. Sands, S. J. Haswell, S. M. Kelly, V. Skelton,
D. O. Morgan, P. Styring and B. Warrington, Lab Chip, 2001, 1, 64; (f)
S. J. Haswell, R. J. Middleton, B. O’Sullivan, V. Skelton, P. Watts and
P. Styring, Chem. Commun., 2001, 5, 391; (g) P. D. I. Fletcher,
S. J. Haswell, E. Pombo-Villar, B. H. Warrington, P. Watts, S. Y. F. Wong
and X. Zhang, Tetrahedron, 2002, 58, 4735; (h) A. M. Hafez, A. E. Taggi
and T. Lectka, Chem.–Eur. J., 2002, 8, 4115; (i) G. Jas and A. Kirschning,
Chem.–Eur. J., 2003, 9, 5708; (j) P. Watts and S. J. Haswell, Curr. Opin.
Chem. Biol., 2003, 7, 380; (k) P. Watts and S. J. Haswell, Drug Discovery
Today, 2003, 8, 586; (l) A. Kirschning and G. Jas, Top. Curr. Chem.,
2004, 209; (m) D. Jo¨nsson, B. H. Warrington and M. Ladlow, J. Comb.
Chem., 2004, 6, 584; (n) H. R. Luckarift, L. J. Nadeau and J. C. Spain,
Chem. Commun., 2005, 383; (o) G. N. Doku, W. Verboom,
D. N. Reinhoudt and A. van den Berg, Tetrahedron, 2005, 61, 2733
and all the references cited therein (a)–(o).
84
5
96
85
3 (a) R. A. Kautz, W. K. Goetzinger and B. L. Karger, J. Comb. Chem.,
2005, 7, 14; (b) D. M. Ratner, E. R. Murphy, M. Jhunjhunwala,
D. A. Snyder, K. F. Jensen and P. H. Seeberger, Chem. Commun., 2005,
5, 578.
6
7
8
92
.95
90
4 The Thales Nanotechnology H-Cube1 flow hydrogenator is currently a
prototype that is due to become available in the coming months.
For further details, please refer to the product details on the company
H-1031 Budapest, Za´hony utca 7 (Graphisoft Park), Hungary.
Fax: +36 16666 190. Tel: +36 1 6666 100.
quant.
quant.
5 Pre-packed cartridges (CatCart1) containing catalyst are available from
Thales Nanotechnology. In this study 30 6 4 mm cartridges
(CatCart130) were used throughout.
90
6 For other applications of flow hydrogenation see: (a) A. J. Sandee,
D. G. I. Petra, J. N. H. Reek, P. C. J. Kamer and P. W. N. M. van
Leeuwen, Chem.–Eur. J., 2001, 7, 1202; (b) N. Ku¨nzle, T. Mallat and
A. Baiker, Appl. Catal., 2003, 238, 251; (c) J. Kobayashi, Y. Mori,
K. Okamoto, R. Akiyama, M. Ueno, T. Kitamori and S. Kobayashi,
Science, 2004, 304, 1305; (d) N. Yoswathananont, K. Nitta, Y. Nishiuchi
and M. Sato, Chem. Commun., 2005, 1, 40.
7 All the imines used in this study were prepared by standard methods
involving reaction of the appropriate carbonyl compound with amines in
the presence of 3 s molecular sieves.
a
quant. 5 quantitative.
linking flow reactors that perform specific synthetic transforma-
tions are currently under way in our laboratory.
8 S. V. Ley, M. H. Bolli, B. Hinzen, A.-G. Gervois and B. J. Hall, J. Chem.
Soc., Perkin Trans. 1, 1998, 353.
This journal is ß The Royal Society of Chemistry 2005
Chem. Commun., 2005, 2909–2911 | 2911